These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26486698)

  • 1. Local Heat Application for the Treatment of Buruli Ulcer: Results of a Phase II Open Label Single Center Non Comparative Clinical Trial.
    Vogel M; Bayi PF; Ruf MT; Bratschi MW; Bolz M; Um Boock A; Zwahlen M; Pluschke G; Junghanss T
    Clin Infect Dis; 2016 Feb; 62(3):342-350. PubMed ID: 26486698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase change material for thermotherapy of Buruli ulcer: a prospective observational single centre proof-of-principle trial.
    Junghanss T; Um Boock A; Vogel M; Schuette D; Weinlaeder H; Pluschke G
    PLoS Negl Trop Dis; 2009; 3(2):e380. PubMed ID: 19221594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase change material for thermotherapy of Buruli ulcer: modelling as an aid to implementation.
    Braxmeier S; Hellmann M; Beck A; Umboock A; Pluschke G; Junghanss T; Weinlaeder H
    J Med Eng Technol; 2009; 33(7):559-66. PubMed ID: 19591051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.
    Johnson RC; Sáez-López E; Anagonou ES; Kpoton GG; Ayelo AG; Gnimavo RS; Mignanwande FZ; Houezo JG; Sopoh GE; Addo J; Orford L; Vlasakakis G; Biswas N; Calderon F; Della Pasqua O; Gine-March A; Herrador Z; Mendoza-Losana A; Díez G; Cruz I; Ramón-García S
    Trials; 2022 Jul; 23(1):559. PubMed ID: 35804454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "Buruli Score": Development of a Multivariable Prediction Model for Diagnosis of Mycobacterium ulcerans Infection in Individuals with Ulcerative Skin Lesions, Akonolinga, Cameroon.
    Mueller YK; Bastard M; Nkemenang P; Comte E; Ehounou G; Eyangoh S; Rusch B; Tabah EN; Trellu LT; Etard JF
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004593. PubMed ID: 27045293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Buruli Ulcer.
    Kumar S; Basu S; Bhartiya SK; Shukla VK
    Int J Low Extrem Wounds; 2015 Sep; 14(3):217-23. PubMed ID: 26286931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buruli ulcer (Mycobacterium ulcerans infection).
    Walsh DS; Portaels F; Meyers WM
    Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mycobacterium ulcerans disease (Buruli ulcer) in Gabon: 2005-2011].
    Bayonne Manou LS; Portaels F; Eddyani M; Book AU; Vandelannoote K; de Jong BC
    Med Sante Trop; 2013; 23(4):450-7. PubMed ID: 24413612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
    Walsh DS; Portaels F; Meyers WM
    Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a Buruli ulcer community of practice in Bankim, Cameroon: A model for Buruli ulcer outreach in Africa.
    Awah PK; Boock AU; Mou F; Koin JT; Anye EM; Noumen D; Nichter M;
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006238. PubMed ID: 29584724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
    Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
    Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya.
    Walsh DS; Eyase F; Onyango D; Odindo A; Otieno W; Waitumbi JN; Bulimo WD; Schnabel DC; Meyers WM; Portaels F
    Am J Trop Med Hyg; 2009 Dec; 81(6):1110-3. PubMed ID: 19996445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and practices of health practitioners on treatment of Buruli ulcer in the Mbonge, Ekondo Titi and Muyuka Health Districts, South West Region, Cameroon.
    Nsai FS; Cumber SN; Nkfusai NC; Viyoff VZ; Afutendem NB; Cumber RY; Tsoka-Gwegweni JM; Akoachere JTK
    Pan Afr Med J; 2018; 31():228. PubMed ID: 31452829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.
    Vincent QB; Ardant MF; Adeye A; Goundote A; Saint-André JP; Cottin J; Kempf M; Agossadou D; Johnson C; Abel L; Marsollier L; Chauty A; Alcaïs A
    Lancet Glob Health; 2014 Jul; 2(7):e422-30. PubMed ID: 25103396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Epidemiology of Buruli Ulcer from Benin (2005-2013): Effect of Time-Delay to Diagnosis on Clinical Forms and Severe Phenotypes.
    Capela C; Sopoh GE; Houezo JG; Fiodessihoué R; Dossou AD; Costa P; Fraga AG; Menino JF; Silva-Gomes R; Ouendo EM; Rodrigues F; Pedrosa J
    PLoS Negl Trop Dis; 2015; 9(9):e0004005. PubMed ID: 26355838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection.
    Pommelet V; Vincent QB; Ardant MF; Adeye A; Tanase A; Tondeur L; Rega A; Landier J; Marion E; Alcaïs A; Marsollier L; Fontanet A; Chauty A
    Clin Infect Dis; 2014 Nov; 59(9):1256-64. PubMed ID: 25048846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
    Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA
    Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Community-based approaches in the fight against Buruli ulcer : review of the literature].
    Ndongo PY; Fond-Harmant L; Deccache A
    Sante Publique; 2014; 26(1 Suppl):S41-50. PubMed ID: 25380376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions.
    Schütte D; Umboock A; Pluschke G
    Br J Dermatol; 2009 Feb; 160(2):273-83. PubMed ID: 19016694
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.